INIS
patients
100%
comparative evaluations
60%
rats
57%
doses
43%
drugs
35%
hiv
33%
evaluation
33%
analgesics
31%
levels
30%
control
30%
symptoms
25%
hospitals
24%
boron 12
23%
vitamins
23%
data
22%
toxicity
22%
folic acid
22%
pharmacology
22%
children
20%
inflammation
19%
diseases
19%
correlations
19%
india
18%
assessments
17%
hypertension
16%
pain
16%
pediatrics
16%
gum acacia
16%
tuberculosis
15%
diabetes mellitus
15%
receptors
15%
hemoglobin
15%
plates
14%
animals
13%
mice
13%
death
12%
medicine
12%
implementation
12%
latency period
11%
mortality
11%
hemophilus
11%
diuretics
11%
c-reactive protein
11%
antihypertensive agents
11%
rodents
11%
quality of life
11%
malformations
11%
food and drug administration
11%
prophylaxis
11%
titration
11%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
33%
Diabetes Mellitus
32%
Wistar Rat
28%
Analgesic Agent
28%
Gum Arabic
26%
Vitamin B12
23%
Antihypertensive Agent
22%
Adverse Event
22%
Prevalence
17%
Folic Acid Deficiency
16%
Anti-Inflammatory Drug
15%
Non Insulin Dependent Diabetes Mellitus
13%
Antioxidant
13%
Folic Acid
13%
Clinical Pharmacology
11%
Behavioral Toxicity
11%
Pancreatitis
11%
Phyllanthus niruri
11%
Syzygium cumini
11%
Randomized Clinical Trial
11%
Pharmacogenomics
11%
Global Disease Burden
11%
Opiate Receptor
11%
Antinociception
11%
Vanillin
11%
Pyridoxine
11%
Antiinfective Agent
11%
Creatinine
11%
Tocilizumab
11%
Parathyroid Hormone
11%
Hypovitaminosis D
11%
Case-Control Study
11%
Combination Therapy
11%
Sepsis
11%
Vitamin Deficiency
11%
Metabolic Syndrome X
11%
Alocasia
11%
Diuretic Activity
11%
C Reactive Protein
11%
Levetiracetam
11%
Cardiovascular Disease
11%
Bacopa monnieri
11%
Alpinia galanga
11%
Naloxone
8%
Antimicrobial Therapy
7%
Hot Plate Test
6%
Dipeptidyl Carboxypeptidase Inhibitor
6%
Bacopa
6%
Superoxide Dismutase
5%
Antihypertensive Drug
5%
Medicine and Dentistry
Adverse Event
22%
Sepsis
22%
Antioxidant
14%
Drug Therapy
12%
Human Immunodeficiency Virus
11%
Combination Therapy
11%
Sclerotherapy
11%
Submandibular Gland
11%
Vascular Anomaly
11%
Personalized Medicine
11%
Pharmacogenomics
11%
Global Disease Burden
11%
Diuretic Activity
11%
Haemophilus Influenzae Type A
11%
Tocilizumab
11%
Metabolic Syndrome
11%
Pyridoxine
11%
Cardiovascular Disease
11%
Syzygium cumini
11%
C Reactive Protein
11%
Pancreatitis
11%
Pain
11%
Hepatitis B
11%
Biological Marker
11%
Red Blood Cell Distribution Width
11%
Pediatrics
11%
Maturity Onset Diabetes of the Young
11%
Gum Arabic
11%
Randomized Clinical Trial
11%
Analgesic Activity
11%
Antihypertensive Agent
11%
Quality of Life
11%
Hypovitaminosis D
11%
Parathyroid Hormone
11%
Hormone Response
11%
Hypovitaminosis
11%
Case-Control Study
11%
Diabetes Mellitus
9%
Naloxone
9%
Hot Plate Test
9%
Sialolithiasis
7%
Salivary Gland
7%
Anodyne
6%
Superoxide Dismutase
5%
Vitamin D
5%
